<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Overall 130 patients with circulatory (atherosclerotic) <z:hpo ids='HP_0001298'>encephalopathy</z:hpo> were examined for the clinical picture, cerebral hemodynamics, specific features of the treatment and catamnesis at different disease stages </plain></SENT>
<SENT sid="1" pm="."><plain>Use was made of ultrasound, rheographic and radionuclide research methods for intracranial arterial and venous blood flow </plain></SENT>
<SENT sid="2" pm="."><plain>The data thus obtained were compared to the computer-aided tomography of the brain data </plain></SENT>
<SENT sid="3" pm="."><plain>It has been discovered that cerebral hemodynamic disorders and brain <z:mpath ids='MPATH_127'>atrophy</z:mpath> are related to insufficiency of circulation via the main intracranial arteries and blood <z:mpath ids='MPATH_105'>circulatory disorders</z:mpath> in the microvessels </plain></SENT>
<SENT sid="4" pm="."><plain>The clinical and hemodynamic efficacy of vasoactive and metabolic therapy (cavinton, piracetam, stugeron combined with complamine++) varied depending on the disease stage </plain></SENT>
</text></document>